This site is intended for health professionals only

COVID-19 of short duration with low symptom burden in children

An analysis of adult proxy reported symptoms found that COVID-19 in children has a short duration and a low burden of symptoms.

Mortality associated with COVID-19 infection has been associated with increasing age and the presence of several co-morbidities. This suggests that death from COVID-19 in children and adolescents are likely to be much lower and this has been confirmed in studies. However, one analysis found that nearly a quarter (23%) of infected children were asymptomatic and concluded that paediatric transmissibility should not be ignored. Another clinical syndrome that has emerged in children during the pandemic is a new, rare condition termed multisystem inflammatory syndrome (MIS-C), which has features similar to Kawasaki disease and appears 2 – 4 weeks after the onset of COVID-19. While in adults, long COVID has become a recognised post-infection syndrome, it remains unclear whether children can also experience protracted symptoms after an acute infection.

The COVID Symptom Study has been compiling self-reported symptom data from adults via a smartphone app since March 2020. Starting in September 2020, the app was extended to allow for the analysis of data in children and while this data was not self-reported by the children themselves, it was proxy-reported by an adult. The COVID Symptom Study team therefore set out to investigate illness duration and symptom burden in children aged 5 – 17 years and who had tested positive for COVID-19. The data was split into two groups: children aged 5 – 11 years and those 12 – 17 years. The children were considered to be COVID-19 positive where proxy-reported relevant symptoms were present. The primary outcome of interest was illness duration and symptom burden in children who had tested positive for COVID-19. For comparative purposes, the team also included children who tested negative for the virus.

Article continues below this sponsored advert
Featured Image
Explore the latest advances in cardiovascular care delivered by renowned experts from recognised Centres of Excellence and other NHS trusts around the UK. Gain CPD, put your burning questions to the experts, and boost your confidence when it comes to care for your patients.
Advertisement

Findings
A total of 75,529 children had a valid COVID-19 positive test result and 1,734 children (588 in the younger age group) had calculable illness duration. The median illness duration for COVID-19 in children was 6 days and was slightly shorter in younger compared to older children (5 days vs 7 days, younger vs older children, p <0.001). In contrast, this was longer than in children reporting symptoms but who had tested negative for COVID-19 (6 days vs 3 days, COVID-19 positive vs negative). Overall, among children testing positive for COVID-19, 74.5% had fever, cough, anosmia or a combination of these symptoms. The most common symptoms reported were headache (62.2%) and fatigue (55%) and during the first week of illness the median symptom burden was only 3 symptoms for the whole cohort. A total of 77 (4.4%) of children reported that their duration of illness was at least 28 days and this was more common among older than younger children (5.1% vs 3.1%, p = 0.046). Only 25 (1.8%) of children reported experiencing symptoms for at least 56 days.
The authors commented on how in children, infection had a short illness duration and with a low symptom burden. They concluded that it was reassuring to find that symptom burden in children did not increase over time.

Citation
Molteni E et al. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc Health 2021.






Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine

x